{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:34:30Z","timestamp":1740144870370,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T00:00:00Z","timestamp":1672272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T00:00:00Z","timestamp":1672272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009826","name":"University of Colombo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kumi and Heram Bilmoria Trust Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The multistep molecular model of breast carcinogenesis is based on the oestrogen receptor(ER) status of the tumour. Its two main arms comprise ER-positive and ER-negative breast carcinomas(BCa), which are associated with Nottingham grade(NG) of the tumour and different proliferative epithelial changes. According to the model, columnar cell lesions(CCL), lobular carcinoma in-situ(LCIS) and atypical ductal hyperplasia(ADH), low-grade ductal carcinoma in-situ (LG-DCIS) are associated with low grade ER-positive tumours and microglandular adenosis (MGA), pleomorphic LCIS(PLCIS), high-grade DCIS(HG-DCIS) are associated with ER-negative high grade tumours. This study aims to describe the association between proliferative epithelial changes in breast tissue adjacent to tumour, in relation to the ER status and NG of the tumour.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This descriptive cross-sectional study included 420, wide local excision and mastectomy specimens of BCa from National Hospital of Sri Lanka, between 2017\u20132019. The histopathological features of the tumour and proliferative epithelial changes in tumour adjacent tissue within 10\u00a0mm distance from the tumour-host interface were evaluated independently by two pathologists. The ER, PR(Progesterone receptor) and HER2 status assessed by immunohistochemistry(IHC) was reviewed. The associations between above epithelial lesions and ER status and NG{categorised as low grade (NG1 and NG2) and high grade (NG3)} of the tumour were analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>ER positive BCa showed significant associations with CCH (<jats:italic>p<\/jats:italic>\u2009=\u20090.04), FEA (<jats:italic>p<\/jats:italic>\u2009=\u20090.035) and LGDCIS (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Although PLCIS was more frequent in ER positive tumours, the association did not attain statistical significance. ER negative BCa showed a significant association with HGDCIS (<jats:italic>p<\/jats:italic>\u2009=\u20090.016). CCLs as a whole (<jats:italic>p<\/jats:italic>\u2009=\u20090.005) and also CCC (<jats:italic>p<\/jats:italic>\u2009=\u20090.006) and FEA (<jats:italic>p<\/jats:italic>\u2009=\u20090.048) and LGDCIS (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) showed significant associations with low NG tumours. High NG tumours showed a significant association with HGDCIS (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Microglandular adenosis was not identified in our study population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These morphological findings support the multistep molecular based pathogenetic pathways of breast carcinoma in the studied setting in South Asia. Identification of these proliferative epithelial components in a core biopsy that is negative for BCa, should prompt for close clinicoradiological correlation, and if necessary re-biopsy of women suspected of harbouring a BCa.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-022-01281-w","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T05:03:03Z","timestamp":1672290183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Proliferative epithelial changes in tumour adjacent tissue in Sri Lankan women with breast carcinoma: do morphological changes support molecular models of breast carcinogenesis?"],"prefix":"10.1186","volume":"17","author":[{"given":"Indumini Maheshika","family":"Jinadasa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshima Disvini","family":"Wijesinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Modini Manohari Abeydera","family":"Jayawickrama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menaka Dilani Samarawickrama","family":"Lokuhetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,29]]},"reference":[{"issue":"6","key":"1281_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA cancer J Clin"},{"key":"1281_CR2","unstructured":"Cancer incidence and mortality data Sri Lanka 2014.\u00a0Colombo: National Cancer Control Programme;\u00a02021.\u00a0\u00a0https:\/\/www.nccp.health.gov.lk\/storage\/post\/pdfs\/Cancer%20Registry%20-2014%20%20(March).pdf.\u00a0Accessed 5\u00a0Nov 2021."},{"issue":"5","key":"1281_CR3","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s00268-005-0585-9","volume":"31","author":"G Agarwal","year":"2007","unstructured":"Agarwal G, Pradeep PV, Aggarwal V, Yip CH, Cheung PS. Spectrum of breast cancer in Asian women. World J Surg. 2007;31(5):1031\u201340.","journal-title":"World J Surg"},{"issue":"2","key":"1281_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2559.2010.03568.x","volume":"57","author":"MA Lopez-Garcia","year":"2010","unstructured":"Lopez-Garcia MA, Geyer FC, Lacroix-Triki M, Marchi\u00f3 C, Reis-Filho JS. Breast cancer precursors revisited: molecular features and progression pathways. Histopathol. 2010;57(2):171\u201392.","journal-title":"Histopathol"},{"issue":"2","key":"1281_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/path.2808","volume":"223","author":"A Bombonati","year":"2011","unstructured":"Bombonati A, Sgroi DC. The molecular pathology of breast cancer progression. J Pathol. 2011;223(2):308\u201318.","journal-title":"J Pathol"},{"issue":"3","key":"1281_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/01.pas.0000213368.41251.b9","volume":"31","author":"TM Abdel-Fatah","year":"2007","unstructured":"Abdel-Fatah TM, Powe DG, Hodi Z, Lee AH, Reis-Filho JS, Ellis IO. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol. 2007;31(3):417\u201326.","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"1281_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/jnci\/dju165","volume":"106","author":"WF Anderson","year":"2014","unstructured":"Anderson WF, Rosenberg PS, Prat A, Perou CM, Sherman ME. How many etiological subtypes of breast cancer: two, three, four, or more? J Natl Cancer Inst. 2014;106(8):165.","journal-title":"J Natl Cancer Inst"},{"issue":"6797","key":"1281_CR8","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, S\u00f8rlie T, Eisen MB, Van De Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge \u00d8. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747.","journal-title":"Nature"},{"issue":"4","key":"1281_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/gcc.20646","volume":"48","author":"R Natrajan","year":"2009","unstructured":"Natrajan R, Lambros MB, Geyer FC, Marchio C, Tan DS, Vatcheva R, Shiu KK, Hungermann D, Rodriguez-Pinilla SM, Palacios J, Ashworth A. Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype? Genes Chromosomes Cancer. 2009;48(4):351\u201365.","journal-title":"Genes Chromosomes Cancer"},{"key":"1281_CR10","volume-title":"Sample size determination in health studies: a practical manual","author":"SK Lwanga","year":"1991","unstructured":"Lwanga SK, Lemeshow S, World Health Organization. Sample size determination in health studies: a practical manual. 1991."},{"key":"1281_CR11","unstructured":"Lakhani SR, Ellis IO, Schnitt SJ, Tan PH ,van de Vijver MJ (Eds.).WHO classification of tumours of the breast. IARC: Lyon 2012."},{"key":"1281_CR12","unstructured":"Ellis IO, Al-Sam S, Anderson N, Carder P, Deb R, Girling A, et al. Pathology reporting of breast disease in surgical excision specimens incorporating the dataset for histological reporting of breast cancer.\u00a0London: The\u00a0Royal College of Pathologists;\u00a02016.\u00a0https:\/\/www.rcpath.org\/uploads\/assets\/7763be1c-d330-40e8-95d08f955752792a\/G148_BreastDataset-hires-Jun16.pdf.\u00a0Accessed 5 Nov 2021."},{"issue":"11","key":"1281_CR13","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.5858\/arpa.2018-0902-SA","volume":"142","author":"AC Wolff","year":"2018","unstructured":"Wolff AC, Hammond ME, Allison KH, Harvey BE, Mangu PB, Bartlett JM, Bilous M, Ellis IO, Fitzgibbons P, Hanna W, Jenkins RB. Human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology\/College of American Pathologists clinical practice guideline focused update. Arch Pathol Lab Med. 2018;142(11):1364\u201382.","journal-title":"Arch Pathol Lab Med"},{"issue":"90","key":"1281_CR14","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.18410\/jebmh\/2016\/1029","volume":"3","author":"S Rema Nair","year":"2016","unstructured":"Rema Nair S, Himaja S, Bhagyalakshmi A. Prospective study of histological proliferative changes in adjacent areas of breast cancer. J Evid Based Med Healthc. 2016;3(90):4881\u20135.","journal-title":"J Evid Based Med Healthc"},{"issue":"8","key":"1281_CR15","doi-asserted-by":"crossref","first-page":"574","DOI":"10.7439\/ijbr.v6i8.2304","volume":"6","author":"R Shashikala","year":"2015","unstructured":"Shashikala R, Ravindra S. Proliferative fibrocystic lesions in association with carcinoma breast-study of mastectomy specimens. Int J Biomed Adv Res. 2015;6(8):574\u20139.","journal-title":"Int J Biomed Adv Res"},{"issue":"4","key":"1281_CR16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/PAS.0b013e318161d1a5","volume":"32","author":"TM Abdel-Fatah","year":"2008","unstructured":"Abdel-Fatah TM, Powe DG, Hodi Z, Reis-Filho JS, Lee AH, Ellis IO. Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family. Am J Surg Pathol. 2008;32(4):513\u201323.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"1281_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1309\/5HC4YYVJL73WGYHX","volume":"130","author":"AM Carley","year":"2008","unstructured":"Carley AM, Chivukula M, Carter GJ, Karabakhtsian RG, Dabbs DJ. Frequency and clinical significance of simultaneous association of lobular neoplasia and columnar cell alterations in breast tissue specimens. Am J Clin Pathol. 2008;130(2):254\u20138.","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"1281_CR18","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00428-005-0018-z","volume":"447","author":"S Fern\u00e1ndez-Aguilar","year":"2005","unstructured":"Fern\u00e1ndez-Aguilar S, Simon P, Buxant F, Simonart T, No\u00ebl JC. Tubular carcinoma of the breast and associated intra-epithelial lesions: a comparative study with invasive low-grade ductal carcinomas. Virch Archiv. 2005;447(4):683\u20137.","journal-title":"Virch Archiv"},{"issue":"4","key":"1281_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.amjsurg.2004.06.037","volume":"188","author":"MM Guerra-Wallace","year":"2004","unstructured":"Guerra-Wallace MM, Christensen WN, White RL Jr. A retrospective study of columnar alteration with prominent apical snouts and secretions and the association with cancer. Am J Surg. 2004;188(4):395\u20138.","journal-title":"Am J Surg"},{"issue":"3","key":"1281_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/PAP.0b013e31816ff313","volume":"15","author":"SM Brandt","year":"2008","unstructured":"Brandt SM, Young GQ, Hoda SA. The \u201cRosen Triad\u201d: tubular carcinoma, lobular carcinoma in situ, and columnar cell lesions. Adv Anat Pathol. 2008;15(3):140\u20136.","journal-title":"Adv Anat Pathol"},{"issue":"6","key":"1281_CR21","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1097\/01.pas.0000157295.93914.3b","volume":"29","author":"PT Simpson","year":"2005","unstructured":"Simpson PT, Gale T, Reis-Filho JS, Jones C, Parry S, Sloane JP, Hanby A, Pinder SE, Lee AH, Humphreys S, Ellis IO. Columnar cell lesions of the breast: the missing link in breast cancer progression?: a morphological and molecular analysis. Am J Surg Pathol. 2005;29(6):734\u201344.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1281_CR22","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<521::AID-PATH472>3.0.CO;2-B","volume":"189","author":"H Buerger","year":"1999","unstructured":"Buerger H, Otterbach F, Simon R, Sch\u00e4fer KL, Poremba C, Diallo R, Brinkschmidt C, Dockhorn-Dworniczak B, Boecker W. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol. 1999;189(4):521\u20136.","journal-title":"J Pathol"},{"issue":"7","key":"1281_CR23","first-page":"1433","volume":"59","author":"R Roylance","year":"1999","unstructured":"Roylance R, Gorman P, Harris W, Liebmann R, Barnes D, Hanby A, Sheer D. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res. 1999;59(7):1433\u20136.","journal-title":"Cancer Res"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-022-01281-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-022-01281-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-022-01281-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T05:05:57Z","timestamp":1672290357000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-022-01281-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,29]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1281"],"URL":"https:\/\/doi.org\/10.1186\/s13000-022-01281-w","relation":{},"ISSN":["1746-1596"],"issn-type":[{"type":"electronic","value":"1746-1596"}],"subject":[],"published":{"date-parts":[[2022,12,29]]},"assertion":[{"value":"11 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Ethical Review Committee of the National Hospital of Sri Lanka, Colombo (Ref AAJ\/ETH\/COM\/2020\/JULY).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}